Magnus Johannesson | Academic Influence

Magnus Johannesson's AcademicInfluence.com Rankings

Magnus Johannesson

Economics

#2143

World Rank

#2449

Historical Rank

Behavioral Economics

#27

World Rank

#27

Historical Rank

economics Degrees

Download Badge

Economics

Magnus Johannesson's Degrees

PhD Economics Stockholm School of Economics
Masters Economics Stockholm School of Economics
Bachelors Economics Stockholm School of Economics

Similar Degrees You Can Earn

Why Is Magnus Johannesson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gunnar Magnus Johannesson is a professor at the Stockholm School of Economics, as well as a former member of the Committee for the Prize in Economic Sciences in Memory of Alfred Nobel. He is known for his research in the field of experimental economics.

(See a Problem?)

Magnus Johannesson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estimating the reproducibility of psychological science (2015) (5547)
Redefine statistical significance (2017) (1806)
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals (2018) (1401)
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. (2003) (1155)
Genome-wide association study identifies 74 loci associated with educational attainment (2016) (1114)
Evaluating replicability of laboratory experiments in economics (2016) (835)
Evaluating the replicability of social science experiments in Nature and Science between 2010 and 2015 (2018) (826)
GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment (2013) (803)
Swedish population health-related quality of life results using the EQ-5D (2004) (673)
Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions (2015) (651)
Crowding Out in Blood Donation: Was Titmuss Right? (2008) (618)
Pride and Prejudice: The Human Side of Incentive Theory (2006) (614)
Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses (2016) (563)
Multi-trait analysis of genome-wide association summary statistics using MTAG (2017) (525)
Genetic Variation in Preferences for Giving and Risk Taking (2009) (503)
The relationship between happiness, health, and socio-economic factors : Results based on Swedish microdata (2001) (487)
Variability in the analysis of a single neuroimaging dataset by many teams (2019) (476)
Promises, Threats and Fairness (2004) (437)
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences (2019) (421)
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences (2019) (421)
Gender differences in deception (2008) (403)
Many Analysts, One Data Set: Making Transparent How Variations in Analytic Choices Affect Results (2018) (394)
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. (1997) (394)
Eliciting Willingness to Pay Without Bias: Evidence from a Field Experiment (2008) (390)
On the decision rules of cost-effectiveness analysis. (1993) (382)
Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence (2017) (380)
Heritability of cooperative behavior in the trust game (2008) (347)
The Aversion to Lying (2009) (331)
Polygenic risk scores for schizophrenia and bipolar disorder predict creativity (2015) (317)
The Swedish Twin Registry: Establishment of a Biobank and Other Recent Developments (2012) (303)
Testing guilt aversion (2010) (291)
Genetic Variation in Financial Decision Making (2009) (286)
Genetic Associations with Subjective Well-Being Also Implicate Depression and Neuroticism (2015) (276)
Common genetic variants associated with cognitive performance identified using the proxy-phenotype method (2014) (262)
Most Reported Genetic Associations With General Intelligence Are Probably False Positives (2012) (262)
Swedish experience-based value sets for EQ-5D health states (2013) (261)
The Contingent-valuation Method (1993) (261)
The genetic architecture of economic and political preferences (2012) (256)
Health-related quality of life by disease and socio-economic group in the general population in Sweden. (2001) (253)
Genome-wide analysis identifies 12 loci influencing human reproductive behavior (2016) (250)
An experimental comparison of dichotomous choice contingent valuation questions and real purchase decisions (1998) (249)
Intuition and cooperation reconsidered (2013) (243)
Social framing effects: Preferences or beliefs? (2012) (242)
Hypothetical versus real willingness to pay in the health care sector: results from a field experiment. (2001) (242)
Experimental Results on Expressed Certainty and Hypothetical Bias in Contingent Valuation (1998) (237)
Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. (2000) (236)
A note on the effect of unemployment on mortality. (2003) (235)
Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. (1996) (230)
Heritability of ultimatum game responder behavior (2007) (221)
Willingness to pay for antihypertensive therapy--results of a Swedish pilot study. (1991) (212)
Economic evaluation in health care: is there a role for cost-benefit analysis? (1991) (210)
Absolute Income, Relative Income, Income Inequality, and Mortality (2004) (202)
Quality of life, health‐state utilities and willingness to pay in patients with psoriasis and atopic eczema (1999) (202)
Using prediction markets to estimate the reproducibility of scientific research (2015) (200)
The Willingness to Pay for In Vitro Fertilization: A Pilot Study Using Contingent Valuation (1994) (197)
Theory and methods of economic evaluation of health care. (1996) (195)
Assessing the Robustness of Power Posing (2015) (194)
Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008 (2010) (194)
A randomized trial of the effect of estrogen and testosterone on economic behavior (2009) (193)
The friction cost method: a comment. (1997) (189)
The Promises and Pitfalls of Genoeconomics* (2012) (187)
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) (1996) (183)
Outcome measurement in economic evaluation. (1996) (181)
Paying Respect (2007) (178)
Do people care about social context? Framing effects in dictator games (2012) (176)
Is generosity involuntary (2007) (176)
Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. (1997) (171)
A Note on Confidence Intervals in Cost-Effectiveness Analysis (1998) (164)
Business cycles and mortality: results from Swedish microdata. (2005) (158)
Genetic Influences on Political Ideologies: Twin Analyses of 19 Measures of Political Ideologies from Five Democracies and Genome-Wide Findings from Three Populations (2014) (158)
Anchoring and cognitive ability (2010) (155)
On the measurement of relative and absolute income-related health inequality. (2002) (149)
Characterizing QALYs by Risk Neutrality (1997) (146)
Smoking is associated with mosaic loss of chromosome Y (2015) (145)
Directional dominance on stature and cognition in diverse human populations (2015) (144)
Anticipated verbal feedback induces altruistic behavior (2008) (143)
Editorial: Some reflections on cost‐effectiveness analysis (1998) (142)
The Relationship between Health-state Utilities and the SF-12 in a General Population (1999) (140)
The Molecular Genetic Architecture of Self-Employment (2013) (137)
Is the valuation of a QALY gained independent of age? Some empirical evidence. (1997) (136)
Subjective Well-Being and Its Association with Subjective Health Status, Age, Sex, Region, and Socio-economic Characteristics in a Chinese Population Study (2016) (136)
Registered Replication Report: Rand, Greene, and Nowak (2012) (2017) (136)
Willingness to pay for antihypertensive therapy--further results. (1993) (133)
Calibrating Hypothetical Willingness to Pay Responses (1999) (133)
Limbic Justice—Amygdala Involvement in Immediate Rejection in the Ultimatum Game (2011) (131)
The value of private safety versus the value of public safety (1996) (131)
On the Value of Changes in Life Expectancy: Blips Versus Parametric Changes (1997) (129)
A comparison of individual and social time trade-off values for health states in the general population. (2006) (125)
Higher cognitive ability is associated with lower entries in a p-beauty contest (2009) (125)
An Experimental Test of a Theoretical Foundation for Rating-scale Valuations (1997) (125)
Molecular Genetics and Economics. (2011) (119)
The relationship between cost-effectiveness analysis and cost-benefit analysis. (1995) (117)
Comparing meta-analyses and preregistered multiple-laboratory replication projects (2019) (116)
To be, or not to be, that is the question: An empirical study of the WTP for an increased life expectancy at an advanced age (1996) (114)
Resource Utilization and Costs of Stroke Unit Care Integrated in a Care Continuum: A 1-Year Controlled, Prospective, Randomized Study in Elderly Patients: The Göteborg 70+ Stroke Study (2000) (114)
Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. (1998) (112)
A Note on QALYs, Time Tradeoff, and Discounting (1994) (111)
Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies (2003) (110)
Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine (1999) (110)
Is There a Hold-Up Problem? (2004) (110)
Does parametric fMRI analysis with SPM yield valid results?—An empirical study of 1484 rest datasets (2012) (109)
No Association between Oxytocin Receptor (OXTR) Gene Polymorphisms and Experimentally Elicited Social Preferences (2010) (108)
Quality of life and the WTP for an increased life expectancy at an advanced age (1997) (106)
Willingness to Pay for Reductions in Angina Pectoris Attacks (1996) (105)
Eliciting Willingness to Pay without Bias using Follow-up Certainty Statements: Comparisons between Probably/Definitely and a 10-point Certainty Scale (2008) (104)
Genotype–covariate interaction effects and the heritability of adult body mass index (2017) (102)
Willingness to pay for reduced incontinence symptoms. (1997) (101)
Replicability and Robustness of Genome-Wide-Association Studies for Behavioral Traits (2014) (99)
The Validity of QALYs (1997) (96)
Confidence interval estimation tasks and the economics of overconfidence (2003) (95)
Income-related inequality in life-years and quality-adjusted life-years. (2000) (94)
Incorporating Future Costs in Medical Cost-Effectiveness Analysis (1997) (94)
Are boys discriminated in Swedish high schools (2011) (93)
Molecular genetics and subjective well-being (2013) (92)
Some reflections on cost-effectiveness analysis. (1998) (92)
New estimates of the demand for health: results based on a categorical health measure and Swedish micro data. (1999) (92)
Intuition and Moral Decision-Making – The Effect of Time Pressure and Cognitive Load on Moral Judgment and Altruistic Behavior (2016) (90)
The psychometric and empirical properties of measures of risk preferences (2015) (87)
Valuation of health changes with the contingent valuation method: a test of scope and question order effects. (1996) (85)
Regional differences in health status in China: population health-related quality of life results from the National Health Services Survey 2008. (2011) (83)
Non-reciprocal altruism in dictator games (2000) (82)
Increasing socio-economic inequalities in life expectancy and QALYs in Sweden 1980-1997. (2005) (82)
Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals (2022) (80)
Crowd-sourcing Hypothesis Tests: Making Transparent How Design Choices Shape Research Results (2020) (80)
The Relationship between Genes, Psychological Traits, and Political Participation (2014) (80)
The demand for health: results from new measures of health capital (1999) (80)
Deteriorating health status in Stockholm 1998–2002: results from repeated population surveys using the EQ-5D (2007) (79)
Are Healthy-years Equivalents an Improvement over Quality-adjusted Life Years? (1993) (78)
A note on the estimation of the equity-efficiency trade-off for QALYs. (1996) (78)
The Behavioral Genetics of Behavioral Anomalies (2012) (77)
The Decision Rules of Cost-Effectiveness Analysis (1996) (76)
Is Altruism Paternalistic? (2007) (76)
A note on validating Wagstaff and van Doorslaer's health measure in the analysis of inequalities in health. (1999) (74)
The cost-effectiveness of a cardiovascular risk reduction program in general practice. (1997) (74)
Effects of user charges on the use of prescription medicines in different socio-economic groups. (1998) (72)
At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention? (2001) (72)
A health-economic comparison of diet and drug treatment in obese men with mild hypertension. (1992) (70)
Associations of autozygosity with a broad range of human phenotypes (2019) (68)
Time Preference for Health: A Test of Stationarity versus Decreasing Timing Aversion. (2001) (66)
The willingness to pay for health changes, the human-capital approach and the external costs. (1996) (66)
Health-state utilities in a general population in relation to age, gender and socioeconomic factors (1999) (65)
Heritability of Overconfidence (2009) (63)
Conspicuous Generosity (2010) (62)
On the sources of the height–intelligence correlation: New insights from a bivariate ACE model with assortative mating (2010) (62)
The effect of fast and slow decisions on risk taking (2017) (61)
Time spent on waiting lists for medical care: an insurance approach. (1998) (61)
The cost‐effectiveness of treating hypertension in elderly people—an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension) (1993) (60)
Meta-GWAS Accuracy and Power (MetaGAP) Calculator Shows that Hiding Heritability Is Partially Due to Imperfect Genetic Correlations across Studies (2016) (60)
A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. (2017) (60)
An epigenome-wide association study meta-analysis of educational attainment (2017) (60)
Cost-effectiveness analysis of hypertension treatment--a review of methodological issues. (1991) (60)
Patients' willingness to pay for autologous blood donation. (1997) (59)
The Genetic Origins of the Relationship between Psychological Traits and Social Trust (2012) (59)
Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective? (2009) (56)
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. (2000) (55)
Stated Preferences, Real Behaviour and Anchoring: Some Empirical Evidence (1999) (55)
The value of the change in health in Sweden 1980/81 to 1996/97. (2003) (54)
Hypothetical versus real willingness to pay: some experimental results (1997) (53)
Communication: Content or relationship? (2008) (52)
Pre-Birth Factors, Post-Birth Factors, and Voting: Evidence from Swedish Adoption Data (2014) (51)
Cost-utility analysis from a societal perspective. (1997) (51)
Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial. (2016) (51)
Erratum: Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence (2017) (50)
The costs of treating hypertension in Sweden. An empirical investigation in primary health care. (1991) (50)
Urge incontinence. Quality of life and patients' valuation of symptom reduction. (1998) (49)
A note on the depreciation of the societal perspective in economic evaluation of health care. (1995) (48)
A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention. (1991) (48)
Trust and Truth (2009) (48)
The impact of hormone replacement therapy on quality of life and willingness to pay (1996) (48)
Resource profile and user guide of the Polygenic Index Repository (2021) (48)
Predicting replication outcomes in the Many Labs 2 study (2018) (47)
Predicting the replicability of social science lab experiments (2019) (47)
Cost‐benefit analysis of non‐pharmacological treatment of hypertension (1991) (47)
A note on the relationship between ex ante and expected willingness to pay for health care. (1996) (46)
Do Life-Saving Regulations Save Lives? (2002) (46)
Linking Genes and Political Orientations : Cognitive Ability as Mediator Hypothesis (2015) (46)
A comparison of patient and social tariff values derived from the time trade-off method. (1999) (46)
Should we aggregate relative or absolute changes in QALYs? (2001) (45)
Willingness to pay for lipid lowering: a health production function approach (1993) (44)
The costs of treating hypertension--an analysis of different cut-off points. (1991) (44)
Hypothetical versus real payments in Vickrey auctions (1997) (43)
A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women. (2011) (43)
The Co-Twin Methodology and Returns to Schooling - Testing a Critical Assumption (2009) (43)
Perceptions and preferences of autologous blood donors (1998) (42)
Economic evaluation of lipid lowering--a feasibility test of the contingent valuation approach. (1992) (42)
The impact of risk information on patients' willingness to pay for autologous blood donation. (1998) (41)
Genetic and Environmental Influences on the Relationship between Flow Proneness, Locus of Control and Behavioral Inhibition (2012) (41)
Estimating the Impact of Education on Political Participation: Evidence from Monozygotic Twins in the United States, Denmark and Sweden (2016) (40)
Consumption and Health (2006) (40)
#EEGManyLabs: Investigating the replicability of influential EEG experiments (2020) (40)
The intuitive cooperation hypothesis revisited: a meta-analytic examination of effect size and between-study heterogeneity (2019) (39)
A COMPUTER MODEL TO ANALYZE THE COST-EFFECTIVENESS OF HORMONE REPLACEMENT THERAPY (1999) (39)
MTAG: Multi-Trait Analysis of GWAS (2017) (38)
Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature. (1999) (38)
Value for money? A contingent valuation study of the optimal size of the Swedish health care budget. (1995) (38)
Education and Social Trust: Testing a Causal Hypothesis Using the Discordant Twin Design (2017) (37)
Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluations. (1994) (37)
Gender differences in social framing effects (2013) (37)
Economic Evaluation of Hypertension Treatment (1992) (36)
On the Discounting of Gained life-Years in Cost-Effectiveness Analysis (1992) (36)
Discrimination against students with foreign backgrounds: evidence from grading in Swedish public high schools (2015) (36)
The cost‐effectiveness of a cardiovascular multiple‐risk‐factor intervention programme in treated hypertensive men (1995) (36)
Avoiding Double-Counting in Pharmacoeconomic Studies (1997) (35)
The Impact of Age on the Cost - Effectiveness of Hypertension Treatment (1994) (35)
The Ranking Properties of Healthy-Years Equivalents and Quality-Adjusted Life-Years Under Certainty and Uncertainty (1995) (35)
Sunk costs and fairness in incomplete information bargaining (2005) (35)
Some further experimental results on hypothetical versus real willingness to pay (1997) (33)
Distinct Loci in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster Are Associated With Onset of Regular Smoking (2013) (33)
Time is not money (2009) (30)
The Concept of Cost in the Economic Evaluation of Health Care: A Theoretical Inquiry (1994) (30)
Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma (2012) (30)
Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour (2021) (29)
The economics of ageing: on the attitude of Swedish people to the distribution of health care resources between the young and the old. (1996) (28)
Creative destruction in science (2020) (27)
Cost-effectiveness analysis and capital costs. (1998) (27)
The discounting of lives saved in future generations--some empirical results. (1996) (27)
fMRI data of mixed gambles from the Neuroimaging Analysis Replication and Prediction Study (2019) (27)
The cost-effectiveness of the switch towards more expensive antihypertensive drugs. (1994) (26)
Personality Polygenes, Positive Affect, and Life Satisfaction (2016) (26)
Experimental Game Theory and Behavior Genetics (2009) (26)
QALYs, HYEs and individual preferences--a graphical illustration. (1994) (25)
The heritability of moral standards for everyday dishonesty (2013) (24)
Quality-adjusted life-years versus healthy-years equivalents. (1995) (24)
From principle to public policy: using cost-effectiveness analysis. (1994) (24)
Is research in social psychology politically biased? Systematic empirical tests and a forecasting survey to address the controversy (2018) (23)
Systematizing Confidence in Open Research and Evidence (SCORE) (2021) (23)
An Experimental Investigation of Election Promises (2018) (23)
A pilot test of using the veil of ignorance approach to estimate a social welfare function for income (1995) (23)
Multi-trait analysis of genome-wide association summary statistics using MTAG (2018) (22)
Do people care about social context? Framing effects in dictator games (2012) (22)
Does Gender Diversity Promote Nonconformity? (2017) (22)
Corrigendum: Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses (2016) (22)
The Effect of Changes in Treatment Patterns on Drug Expenditure (2012) (21)
Genome-wide study identifies 611 loci associated with risk tolerance and risky behaviors (2018) (21)
The Effect of Competition on Physical Activity: A Randomized Trial (2010) (21)
Health State Utilities in Gastroesophageal Reflux Disease Patients with Heartburn: A Study in Germany and Sweden (2004) (21)
On the estimation of cost-effectiveness ratios. (1995) (21)
On aggregating QALYs: a comment on Dolan. (1999) (20)
An experimental test of question framing in health state utility assessment. (1998) (20)
Economic evaluation of osteoporosis prevention. (1993) (19)
Saving Lives in the Present Versus Saving Lives in the Future—Is There a Framing Effect? (1997) (19)
The digit ratio (2D:4D) and economic preferences: no robust associations in a sample of 330 women (2019) (19)
The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment. (1996) (18)
Are replication rates the same across academic fields? Community forecasts from the DARPA SCORE programme (2020) (18)
Is Financial Risk-Taking Behavior Genetically Transmitted? (2008) (17)
Are women more generous than men? A meta-analysis (2020) (17)
Economic evaluation of drug therapy: a review of the contingent valuation method. (1992) (16)
Economic evaluation in healthcare. A brief history and future directions. (1996) (16)
Economic evaluation of drugs and its potential uses in policy making. (1995) (16)
Contingent valuation with an open-ended follow-up question: a test of scope effects. (1997) (16)
The value of life extension and the marginal rate of time preference: a pilot study (1997) (16)
Subliminal influence on generosity (2017) (15)
Urge Incontinence (1998) (15)
A creative destruction approach to replication: Implicit work and sex morality across cultures (2021) (15)
The contingent valuation method--appraising the appraisers. (1993) (15)
Incorporating quality of life changes into economic evaluations of health care: an overview. (1996) (15)
The cost of screening for hypercholesterolaemia--results from a clinical trial in Swedish primary health care. (1993) (14)
Hormonal Contraceptives Do Not Impact Economic Preferences: Evidence from a Randomized Trial (2017) (14)
2D:4D Does Not Predict Economic Preferences: Evidence from a Large, Representative Sample (2020) (14)
Do Women Have a Less Entrepreneurial Personality (2012) (14)
Reciprocity in young children (2007) (14)
Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diuretics. (1993) (14)
A note on prevention versus cure. (1997) (13)
The Impact of Physician Preferences and Patient Habits on the Diffusion of New Drugs (2002) (13)
Predicting replicability—Analysis of survey and prediction market data from large-scale forecasting projects (2021) (13)
Economic Evaluation in Healthcare (1996) (13)
The costs and effects of two different lipid intervention programmes in primary health care (1995) (13)
Equivalence of LD-Score Regression and Individual-Level-Data Methods (2017) (13)
The cost of lying (2007) (13)
Does Impartial Deliberation Breed Fair Behavior? (2005) (12)
The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing? (1992) (12)
The Cost Effectiveness of Hypertension Treatment in Sweden (1995) (12)
The Revealed Preference Approach (1996) (12)
Ethnic discrimination in high school grading: Evidence from a field experiment (2011) (12)
Economic evaluation of health care and policymaking. (1995) (11)
Sunk Costs, Fairness, and Disagreement (2001) (11)
The Psychology of the Entrepreneur and the Gender Gap in Entrepreneurship (2012) (11)
Use of Misoprostol in the Elderly (1996) (10)
Using prediction markets to forecast research evaluations (2015) (10)
A Review of Cost-Effectiveness Analyses of Hypertension Treatment (1992) (10)
Bargaining Over a Common Good with Private Information (2009) (10)
Cost-benefit aspects of treatment of hypertension in the elderly. (1995) (10)
Consensus-based guidance for conducting and reporting multi-analyst studies (2021) (10)
Replication and other practices for improving scientific quality in experimental economics (2019) (10)
Genome-wide analysis identifies genetic effects on reproductive success and ongoing natural selection at the FADS locus (2020) (9)
Cost-utility analysis and varying preferences for health (1997) (9)
Characterizing QALYs by means of risk neutrality (1997) (9)
Drug Expenditure and New Drug Introductions (1993) (8)
The Contingent Valuation Controversy in Environmental Economics and its Relevance to Health Services Research (1996) (8)
How to assess the economics of hypertension control programmes. (1996) (8)
Characterising QALY's by risk neutrality (1998) (8)
Economics, Pharmaceuticals, and Pharmacoeconomics (1998) (8)
Generosity and Political Preferences (2012) (8)
Qalys: A comment (1995) (7)
The psychometric and empirical properties of measures of risk preferences (2017) (7)
Statistical Significance and the Replication Crisis in the Social Sciences (2019) (7)
Do people care about context? Framing effects in dictator games (2011) (6)
Comparing Meta-Analyses and Pre-Registered Multiple Labs Replication Projects (2019) (6)
Can monetary incentives increase organ donations (2016) (6)
The Impact of User Charges on the Consumption of Drugs (1996) (6)
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences (2019) (6)
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences (2019) (6)
The Australian Guidelines for Subsidisation of Pharmaceuticals (1992) (5)
Crowdsourcing Hypothesis Tests (2016) (5)
Use of misoprostol in the elderly: is the expense justified? (1996) (5)
The intuitive cooperation hypothesis revisited: a meta-analytic examination of effect size and between-study heterogeneity (2020) (5)
PDG27: HEALTH STATE UTILITIES IN GERD PATIENTS WITH HEARTBURN A STUDY IN GERMANY AND SWEDEN (2001) (5)
Genetic influences on economic preferences (2007) (5)
Examining the generalizability of research findings from archival data (2022) (4)
Economic Evaluation of Drug Therapy (1992) (4)
Author Correction: Comparing meta-analyses and preregistered multiple-laboratory replication projects (2020) (4)
Cost-benefit analysis of lipid lowering therapy. (1997) (4)
The Australian Guidelines for Subsidisation of Pharmaceuticals (1992) (4)
BUCHANAN'S OPPORTUNITY COST CONCEPT, THE CONTINGENT VALUATION METHOD AND COSTBENEFIT ANALYSIS (1991) (4)
Registered Replication Report : Rand, Greene & Nowak (2012) (2017) (4)
Publisher Correction: Multi-trait analysis of genome-wide association summary statistics using MTAG (2019) (4)
Identification of and Correction for Publication Bias: Comment (2019) (4)
Erratum: Common genetic variants associated with cognitive performance identified using the proxy-phenotype method (Proc Natl Acad Sci USA (2014) 111 (13790-13794) DOI: 10.1073/pnas.1404623111) (2015) (4)
Drug expenditure and new drug introductions: the Swedish experience. (1993) (4)
The Estimation of Costs (1996) (3)
•On the Role of Theory in Cost-Effectiveness Analysis- A Response to Garber, Russell, and Weinstein (1999) (3)
Large-scale genetic study of risk tolerance and risky behaviors identifies new loci and reveals shared genetic influences (2017) (3)
Saving lives in the present versus saving lives in the future — Is there a framing effect? (1998) (3)
Genetic Variation in Financial Decision Making Forthcoming (2009) (3)
A Report of the ISPOR Health Science Committee – Task Force on Good Research Practices – Modeling Studies (2003) (3)
An epigenome-wide association study of educational attainment (n = 10,767) (2017) (3)
Using prediction markets to predict the outcomes in the Defense Advanced Research Projects Agency's next-generation social science programme (2021) (3)
Cost-Effectiveness of Antihypertensive Treatment (2012) (3)
2D:4D and Self-Employment: A Preregistered Replication Study in a Large General Population Sample (2021) (3)
Regulating chemical accumulation in the environment: The value of changes in health risks: a review (1998) (2)
Why Labels Affect Cooperation (2009) (2)
fMRI data of mixed gambles from the Neuroimaging Analysis Replication and Prediction Study (2019) (2)
Contemporary Issues Use of Contingent Valuation to Place a Monetary Value on Pharmacy Services: An Overview and Review of the Literature (1999) (2)
The effect of fast and slow decisions on risk taking (2017) (2)
Has the Cost-effectiveness of Misoprostol Been Underestimated?-Reply (1995) (2)
Guest Editors’ Preface to the Special Symposium on Field Experiments (2013) (2)
2D:4D and Self-Employment Using SOEP Data: A Replication Study (2020) (2)
Billiards and Brains: Cognitive Ability and Behavior in a p-Beauty Contest (2007) (2)
Price Indices of Drugs and the Switching to New Drugs (2012) (2)
[Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women]. (1991) (2)
PMD25 ELICITING WILLINGNESS TO PAY WITHIN THE HEALTH SECTOR WITHOUT BIAS (2004) (1)
The Expressed Preference Approach (1996) (1)
MTAG: multi-trait analysis of GWAS implicates novel loci for depressive symptoms, neuroticism, and subjective well-being (2017) (1)
Are men discriminated in Swedish high schools? (2010) (1)
98 The cost-effectiveness of treating hypertension in the elderly: an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) (1993) (1)
Pre-registration Politics in Science Survey (2016) (1)
The Determinants of Health in Sweden (2002) (1)
Are SNPs associated with educational attainment also associated with cognitive function (2013) (1)
Sex hormones and economic decision making in the lab (2018) (1)
Data from: Are replication rates the same across academic fields? community forecasts from the DARPA SCORE program (2021) (1)
Politics in Science Project_Pre-Registration Document for Gatekeepers Project (2017) (1)
Cost-Effectiveness Analysis (1996) (1)
[Treatment of hypertension at a health center. 2: The patients' expenses in connection with transport and time are more than a tenth of the total treatment costs]. (1991) (1)
[Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year]. (1991) (1)
Author Correction: Comparing meta-analyses and preregistered multiple-laboratory replication projects (2020) (1)
Limbic justice : Amygdala drives rejection in ultimatum game (2010) (0)
Replication of Kuziemko et al. 2014 (2016) (0)
www.econstor.eu Mental accounting in the Housing Market (2010) (0)
The aaersion to lying (2018) (0)
PAR14: ASSESSMENT OF THE RELATIONSHIP BETWEEN DISEASE SEVERITY, QUALITY OF LIFE AND WILLINGNESS TO PAY IN ASTHMA (2001) (0)
University of Groningen Personality Polygenes , Positive Affect , and Life Satisfaction (2016) (0)
Forecasting the publication and citation outcomes of COVID-19 preprints (2022) (0)
Can laypeople predict the replicability of social science studies without expert intervention: an exploratory study (2022) (0)
The demand for health: some results based on new measures of health capital (1999) (0)
Cost-Utility Analysis (1996) (0)
Complete Repository (*.zip) (2018) (0)
Redefine statistical significance (2017) (0)
Additional Issues in Cost-Benefit Analysis (1996) (0)
Geneticinfluences on flow proneness and its relationship to behavioral inhibition andlocus of control (2012) (0)
Replication of Charness & Dufwenberg 2011 (2016) (0)
Replication of Dulleck et al. 2011 (2016) (0)
Subjective Well-Being and Its Association with Subjective Health Status, Age, Sex, Region, and Socio-economic Characteristics in a Chinese Population Study (2015) (0)
Supplementary material from "Are replication rates the same across academic fields? Community forecasts from the DARPA SCORE program" (2020) (0)
Replication of Hauser et al (2014) (2016) (0)
The Monetary Value of Health Changes (1996) (0)
Replication of Duffy & Puzzello 2014 (2016) (0)
CEP Discussion Paper No 1225 June 2013 Molecular Genetics and Subjective Well-Being (2013) (0)
Comment on Botond Köszegi: On the feasibility of market solutions to self-control problems (2005) (0)
Replication of Abeler et al. (AER 2011) (2016) (0)
Replication of TJ Pleskac (2008, JEPLMC 34(1)) (2014) (0)
ONLINE APPENDIX for Genetics and Economics (2011) (0)
Abstract 4683: Smoking is associated with mosaic loss of chromosome Y (2015) (0)
Commentary From Principle To Public Policy : Using Cost-Effectiveness Analysis (2001) (0)
Replication of Kirchler et al. 2012 (2016) (0)
1 Title : Redefine Statistical Significance (2017) (0)
Evaluating the replicability of social science experiments in Nature and Science between 2010 and 2015 (2018) (0)
Private Information in Common Pools (2012) (0)
Datasets from a research project examining the role of politics in social psychological research (2018) (0)
The Empirical and Psychometric Properties of Measures of Economic Risk Preferences (2017) (0)
Cost Effectiveness and Allocation of Therapies in a Treating Population (1997) (0)
Market, survey and aggregated replication data (2016) (0)
2D:4D and Economic Preferences in a Large Representative Sample of Germans (2018) (0)
Publisher Correction: Identification of 371 genetic variants for age at first sex and birth linked to externalising behavior (2021) (0)
Comparing meta-analyses and preregistered multiple-laboratory replication projects (2019) (0)
Kogan et al. 2011 (2016) (0)
Experimental Economics Replication Project (2016) (0)
Special issue: International comparability of DRGs. (1991) (0)
Subliminal influence on generosity (2016) (0)
Estimating the Impact of Education on Political Participation: Evidence from Monozygotic Twins in the United States, Denmark and Sweden (2016) (0)
Genetic influences on flow proneness and its relationship to behavioral inhibition and locus of control (2012) (0)
Replication of Friedman & Oprea 2012 (2016) (0)
Social Sciences Replication Project (2016) (0)
Author Correction: Multi-trait analysis of genome-wide association summary statistics using MTAG (2019) (0)
Replication of Rand et al (2012) (2016) (0)
The Contraceptive Pill, Well-Being, and Sexual Function (2015) (0)
Replication of Kidd and Castano (2013) (2016) (0)
Replication of Ambrus & Greiner 2012 (2016) (0)
CorrespondanceThe authors reply (1996) (0)
Replication of Fehr et al. 2013 (2016) (0)
PMT28: HEALTH RELATED QUALITY OF LIFE IN A GENERAL SWEDISH POPULATION WITH A GENDER PERSPECTIVE (2000) (0)
Replication of Ericson & Fuster 2011 (2016) (0)
as much to the group. An Appendix with more detailed descriptions of the methods and results are available from the authors. (2013) (0)
Economic Evaluation and Policy Making (1996) (0)
CV4 CORRELATION BETWEEN NEW YORK HEART ASSOCIATION CLASSIFICATION AND PATIENT-REPORTED OUTCOMES (2002) (0)
Examining the shared genetic architecture of risk tolerance and related behaviors (2017) (0)
368 Inhaling hypertonic saline — a useful method to obtain sputum in children and adults with CF (2006) (0)
Organizational Behavior and Human Decision Processes Creative destruction in science ☆ (2021) (0)
Cost benefit of treating hypertension. (1999) (0)
Replication of Nishi et al (2015) (2016) (0)
Cognitive Reflection and 2D:4D: Evidence from a Large Population Sample (2023) (0)
[The 4S study is analysed. Cholesterol reduction is cost-efficient]. (1997) (0)
The Resource Consequences of Health Changes (1996) (0)
Replication of Shah et al (2012) (2016) (0)
Publisher Correction: Multi-trait analysis of genome-wide association summary statistics using MTAG (2019) (0)
Replication of Kessler & Roth 2012 (2016) (0)
Variability in the analysis of a single neuroimaging dataset by many teams (2020) (0)
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals (2018) (0)
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals (2018) (0)
Subliminal In uence on Generosity* (2015) (0)
P848 A randomised trial of the effect of oestrogen and testosterone on economic behaviour (2009) (0)
Replication of Chen & Chen 2011 (2016) (0)
Using prediction markets to forecast research evaluations share how this access benefits you. Your story matters (2015) (0)
Genetic Influences on Political Ideologies: Twin Analyses of 19 Measures of Political Ideologies from Five Democracies and Genome-Wide Findings from Three Populations (2014) (0)
www.econstor.eu Time Is Not Money (2007) (0)
GENDER AND HIRING DECISIONS - Forecasting survey (2020) (0)
Correction: Corrigendum: Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses (2016) (0)

This paper list is powered by the following services:

Other Resources About Magnus Johannesson

en.wikipedia.org

What Schools Are Affiliated With Magnus Johannesson?

Magnus Johannesson is affiliated with the following schools: